TITLE

Prediction of outcome following a first episode of schizophrenia. A follow-up study of Northwick Park first episode study subjects

AUTHOR(S)
Geddes, John; Mercer, Gavin; Frith, C. D.; MacMillan, Fiona; Owens, David G. C.; Johnstone, Eve C.; Geddes, J; Mercer, G; MacMillan, F; Owens, D G; Johnstone, E C
PUB. DATE
November 1994
SOURCE
British Journal of Psychiatry;Nov94, Vol. 165, p664
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: Although previous studies have attempted to identify predictors of outcome in schizophrenia, few have prospectively studied first episode patients for an adequate follow-up period.Method: The psychopathological predictors of outcome were investigated in a subgroup of 51 subjects, originally included in the Northwick Park study of first episode schizophrenia who were followed up 7.3 years (s.d. 1.1, range 5.3-10.3) after first admission in the Harrow study. Forty-four subjects (24 men, 20 women) were traced. Outcome measures were time to first readmission, occupational level and total duration of hospital admission at five years after first admission.Results: A survival analysis of time to first relapse revealed that the presence of subjective feelings of depression (CATEGO syndrome SD) during the first admission was associated with early relapse while the presence of depressive delusions (CATEGO syndrome DD) and higher educational attainment protected against early relapse. Total duration of hospitalisation at five years after first onset was positively associated with the presence of CATEGO syndromes SD and OD (biological features of depression) and negatively associated with female sex. Poor occupational outcome was not significantly associated with any psychopathological predictors.Conclusions: Our findings challenge the conventional view that symptoms of depression are associated with better outcome in schizophrenia.
ACCESSION #
25173801

 

Related Articles

  • Depressive syndromes in the year following onset of a first schizophrenic illness*. House, Allan; Bostock, Janet; Cooper, John; House, A; Bostock, J; Cooper, J // British Journal of Psychiatry;Dec87, Vol. 151, p773 

    A complete, unselected series of 68 patients who were seen during their first episode of an undoubtedly schizophrenic illness, and followed up one year later (for 56 patients) is described clinically. Depressive symptoms were common at onset, and 22% of patients could have been considered cases...

  • Schizophrenia, bipolar disorder and depression. A discriminant analysis, using 'lifetime' psychopathology ratings. Brockington, I.F.; Roper, A.; Copas, J.; Buckley, M.; Andrade, C.E.; Wigg, P.; Farmer, A.; Kaufman, C.; Hawley, R. // British Journal of Psychiatry;Oct91, Vol. 159, p485 

    Discriminant and canonical variate analyses were performed using 302 patients, on whom ratings of lifetime psychopathology and course of illness has been made. DSM-III diagnoses were used to form the criterion groups. Bipolar disorder emerged as a distinct grouping, but there are reasons for...

  • A pilot study of a parent-education group for families affected by depression. Sanford, Mark; Byrne, Carolyn; Williams, Susan; Atley, Sandy; Ridley, Ted; Miller, Jennifer; Allin, Heather // Canadian Journal of Psychiatry;Mar2003, Vol. 48 Issue 2, p78 

    Objective: This study assessed the feasibility and efficacy of a parent-education group for families with young children and a parent with depression. We designed the program to be readily disseminated if shown to be effective. Method: We recruited 44 parents with...

  • Monitoring psychosis in general practice: a controlled trial. Nazareth, Irwin; King, Michael; See Tai, Sharon; Nazareth, I; King, M; Tai, S S // British Journal of Psychiatry;Oct96, Vol. 169, p475 

    Background: This trial evaluated the feasibility, acceptability and effectiveness of a structured approach to the management of schizophrenia in general practice.Method: All patients with non-affective psychosis (mainly schizophrenia) in four inner-city general...

  • Is diazepam an antidepressant? Tiller, John; Schweitzer, Isaac; Maguire, Kay; Davies, Brian; Tiller, J W; Schweitzer, I; Maguire, K P; Davis, B // British Journal of Psychiatry;Oct89, Vol. 155, p483 

    In double-blind sequential study, diazepam was compared with the proven antidepressant moclobemide, in patients with atypical depression. Both agents significantly improved depression ratings over eight weeks of treatment. Diazepam was a significantly better antidepressant than moclobemide at...

  • An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia. Turetz, M.; Mozes, T.; Toren, P.; Chernauzan, N.; Yoran-Hegesh, R.; Mester, R.; Wittenberg, N.; Tyano, S.; Weizman, A. // British Journal of Psychiatry;Jun97, Vol. 170, p507 

    Background: Studies performed with schizophrenic adults who were resistant to classical neuroleptics showed improvement in 30% of the patients when treated with clozapine. Very early onset schizophrenic patients benefit only partially from conventional antipsychotics and are at...

  • Changes in the positive and negative symptoms of schizophrenic in-patients in China. Phillips, Michael A.; Zuan Zhao; Xianzhang Xiong; Xiufang Cheng; Guirong Sun; Ningsheng Wu; Phillips, M R; Zhao, Z A; Xiong, X Z; Cheng, X F; Sun, G R; Wu, N S // British Journal of Psychiatry;Aug91, Vol. 159, p226 

    Positive and negative symptoms at admission and discharge of 401 unselected schizophrenic patients from four psychiatric hospitals around China were studied. On admission 58% of patients had prominent negative symptoms and the overall severity of negative symptoms was similar to that of positive...

  • The effect of peer support on postpartum depression: a pilot randomized controlled trial. Dennis, Cindy-Lee // Canadian Journal of Psychiatry;Mar2003, Vol. 48 Issue 2, p115 

    Objective: To evaluate the effect of peer support (mother-to-mother) on depressive symptomatology among mothers identified as high-risk for postpartum depression (PPD).Method: Forty-two mothers in British Columbia were identified as high-risk for PPD according to the...

  • Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol. Addington, Jean; Addington, Donald; Addington, J; Addington, D // Canadian Journal of Psychiatry;Nov1997, Vol. 42 Issue 9, p983 

    A letter to the editor is presented regarding neurocognitive functioning in schizophrenia: A trial of risperidone versus haloperidol.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics